MedPath

NATIONAL INSTITUTES OF HEALTH

NATIONAL INSTITUTES OF HEALTH logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
Subsidiary, Private
Established
1948-01-01
Employees
1K
Market Cap
-
Website
http://www.nidcr.nih.gov

Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients

Phase 1
Completed
Conditions
Healthy, no Evidence of Disease
Interventions
Other: placebo
Other: pharmacological study
Other: laboratory biomarker analysis
First Posted Date
2007-06-21
Last Posted Date
2014-11-14
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
36
Registration Number
NCT00489372
Locations
πŸ‡ΊπŸ‡Έ

Northwestern University, Chicago, Illinois, United States

πŸ‡ΊπŸ‡Έ

Roswell Park Cancer Institute, Buffalo, New York, United States

Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2
Completed
Conditions
Hormone-Resistant Prostate Cancer
Recurrent Prostate Carcinoma
Interventions
Other: Laboratory Biomarker Analysis
Other: Pharmacological Study
First Posted Date
2007-06-14
Last Posted Date
2017-05-24
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
23
Registration Number
NCT00486642
Locations
πŸ‡¨πŸ‡¦

BCCA-Vancouver Cancer Centre, Vancouver, British Columbia, Canada

πŸ‡¨πŸ‡¦

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada

πŸ‡¨πŸ‡¦

Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, Ontario, Canada

and more 3 locations

Effect of Diet on Vascular Disease in Pre-Menopausal Women

Completed
Conditions
Cardiovascular Diseases
Inflammation
Triglycerides
Insulin
Vascular Disease
First Posted Date
2007-06-11
Last Posted Date
2019-12-17
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Target Recruit Count
47
Registration Number
NCT00484861
Locations
πŸ‡ΊπŸ‡Έ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

Phase 2
Terminated
Conditions
Stage IB Pancreatic Cancer
Stage III Pancreatic Cancer
Stage IA Pancreatic Cancer
Intraductal Papillary Mucinous Neoplasm of the Pancreas
Recurrent Pancreatic Cancer
Stage IIA Pancreatic Cancer
Stage IIB Pancreatic Cancer
Interventions
Procedure: conventional surgery
Other: immunohistochemistry staining method
Genetic: protein expression analysis
Procedure: biopsy
Other: pharmacological study
Other: laboratory biomarker analysis
First Posted Date
2007-06-05
Last Posted Date
2014-10-16
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
6
Registration Number
NCT00482625
Locations
πŸ‡ΊπŸ‡Έ

University of California Medical Center At Irvine-Orange Campus, Orange, California, United States

Cancer Markers Associated With Occupational Exposure to Trichloroethylene

Completed
Conditions
Epidemiology
Neoplasms
Industrial Hygiene
First Posted Date
2007-06-04
Last Posted Date
2020-11-03
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
125
Registration Number
NCT00481611
Locations
πŸ‡¨πŸ‡³

Guangdong National Poison Control Center (NPCC), Guangzhou, China

Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non-Smoking Women in China

Completed
Conditions
Lung Neoplasms
First Posted Date
2007-06-04
Last Posted Date
2020-11-27
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
3720
Registration Number
NCT00482118
Locations
πŸ‡¨πŸ‡³

The University of Hong Kong, Hong Kong, China

πŸ‡¨πŸ‡³

Kunming Medical University, Kunming, China

πŸ‡¨πŸ‡³

China Medical University, Shenyang, China

and more 1 locations

Benign Reproductive Tissue Analysis for Endometrial Cancer Markers

Completed
Conditions
Oophorectomy for Benign Reasons
Hysterectomy
First Posted Date
2007-06-04
Last Posted Date
2020-11-17
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
359
Registration Number
NCT00481754
Locations
πŸ‡ΊπŸ‡Έ

Magee Women's hospital, Pittsburgh, Pennsylvania, United States

Relationship of Genetic Differences to the Development of Chromosome Abnormalities

Terminated
Conditions
Radiation Exposure
First Posted Date
2007-06-04
Last Posted Date
2019-12-17
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
361
Registration Number
NCT00481793
Locations
πŸ‡·πŸ‡Ί

Southern Urals Biophysics Institute, Ozyorsk, Russian Federation

Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Recurrent Non-small Cell Lung Cancer
Stage IIIB Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer
Interventions
Other: placebo
Other: laboratory biomarker analysis
First Posted Date
2007-06-01
Last Posted Date
2014-10-30
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
94
Registration Number
NCT00481078
Locations
πŸ‡ΊπŸ‡Έ

City of Hope, Duarte, California, United States

Radiation Exposure and Thyroid Disease in Kazakhstan

Completed
Conditions
Thyroid Cancer
Thyroid Nodules
Other Thyroid Disease
First Posted Date
2007-05-31
Last Posted Date
2019-12-16
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
117
Registration Number
NCT00480428
Locations
πŸ‡°πŸ‡Ώ

Semipalatinsk State Medical Academy, Semipalatinsk, Kazakhstan

Β© Copyright 2025. All Rights Reserved by MedPath